Literature DB >> 2382062

Two strains of Streptococcus uberis, of differing ability to cause clinical mastitis, differ in their ability to resist some host defence factors.

J A Leigh1, T R Field, M R Williams.   

Abstract

Two strains of Streptococcus uberis (0140J and EF20), previously shown to differ markedly in their ability to infect the mammary gland and cause clinical mastitis, showed correlated differences in their resistance to some host defence mechanisms. Both strains produced a hyaluronic acid capsule but strain 0140J, the more infective, was more resistant than EF20 to phagocytosis and killing by bovine neutrophils. Loss of the capsule from strain EF20 during the stationary phase of growth did not affect its resistance to phagocytosis. Strain 0140J also grew more rapidly than EF20 in raw skimmed milk but dithiothreitol substantially reversed this inhibition, suggesting the involvement of the lactoperoxidase system in the inhibitory effect of raw milk.

Entities:  

Mesh:

Year:  1990        PMID: 2382062

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  16 in total

1.  Killing of Streptococcus uberis by bovine neutrophils following growth in chemically defined media.

Authors:  J A Leigh; T R Field
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

2.  Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis.

Authors:  P N Ward; T R Field; W G Ditcham; E Maguin; J A Leigh
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Molecular epidemiology of Streptococcus uberis isolates from dairy cows with mastitis.

Authors:  P Phuektes; P D Mansell; R S Dyson; N D Hooper; J S Dick; G F Browning
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin.

Authors:  J A Leigh; T R Field
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  The hyaluronic acid capsule of Streptococcus uberis is not required for the development of infection and clinical mastitis.

Authors:  Terence R Field; Philip N Ward; Lars H Pedersen; James A Leigh
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.

Authors:  Emilia Varhimo; Kirsi Savijoki; Jari Jalava; Oscar P Kuipers; Pekka Varmanen
Journal:  J Bacteriol       Date:  2007-05-18       Impact factor: 3.490

7.  Greater expression of TLR2, TLR4, and IL6 due to negative energy balance is associated with lower expression of HLA-DRA and HLA-A in bovine blood neutrophils after intramammary mastitis challenge with Streptococcus uberis.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Juan J Loor
Journal:  Funct Integr Genomics       Date:  2010-03       Impact factor: 3.410

8.  Local vaccination with killed Streptococcus uberis protects the bovine mammary gland against experimental intramammary challenge with the homologous strain.

Authors:  J M Finch; A W Hill; T R Field; J A Leigh
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Changing trends in mastitis.

Authors:  Rn Zadoks; Jl Fitzpatrick
Journal:  Ir Vet J       Date:  2009-04-01       Impact factor: 2.146

10.  Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPARgamma signaling as potential mechanism for the negative relationships between immune response and lipid metabolism.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Massimo Bionaz; Sandra L Rodriguez-Zas; Robin E Everts; Harris A Lewin; Juan J Loor
Journal:  BMC Genomics       Date:  2009-11-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.